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ABSTRACT 21 
The major peptidoglycan hydrolase of E. faecalis, AtlA, has been identified but its enzyme 22 
activity remains unknown. We have used tandem mass spectrometry analysis of peptidoglycan 23 
hydrolysis products obtained using the purified protein to show that AtlA is an N-24 
acetylglucosaminidase. To gain insight into the regulation of its enzyme activity, the three 25 
domains of AtlA were purified alone or in combination following expression of truncated forms 26 
of the atlA gene in E. coli or partial digestion of AtlA by proteinase K. The central domain of 27 
AtlA was catalytically active, but its activity was more than two orders of magnitude lower than 28 
that of the complete protein. Partial proteolysis of AtlA was detected in vivo: zymograms of E. 29 
faecalis extracts revealed two catalytically active protein bands of 62 and 72 kDa that were both 30 
absent in extracts from an atlA null mutant. Limited digestion of AtlA by proteinase K in vitro 31 
suggested that the proteolytic cleavage of AtlA in E. faecalis extracts corresponds to the 32 
truncation of the N-terminal domain, which is rich in threonine and glutamic acid residues. We 33 
show that the truncation of the N-terminal domain from recombinant AtlA has no impact on 34 
enzyme activity. The C-terminal domain of the protein, which contains six LysM modules bound 35 
to highly purified peptidoglycan, was required for optimal enzyme activity. These data indicate 36 
that AtlA is not produced as a proenzyme and that control of the AtlA glucosaminidase activity is 37 
likely to occur at the level of LysM-mediated binding to peptidoglycan. 38 
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INTRODUCTION 39 
Peptidoglycan (or murein) is a major component of the bacterial cell wall. This molecule 40 
forms a bag-shaped exoskeleton enclosing the plasma membrane and protects the cell against 41 
internal osmotic pressure in hypo-osmotic conditions (23). Peptidoglycan consists of glycan 42 
strands of alternating β-1,4-linked N-acetylglucosamine (GlcNAc) and N-acetylmuramic acid 43 
(MurNAc) residues cross-linked to each other by short peptides made of L- and D-amino acids 44 
(20). Throughout growth, the insertion of new precursors and separation of daughter cells 45 
requires limited cleavage of the peptidoglycan molecule (13). The enzymes responsible for this 46 
process are potentially lethal enzymes referred to as autolysins as they cleave the high molecular 47 
weight polymer. In addition to their contribution to cell growth and division, some autolysins 48 
play a role in adhesion (8, 17) and in amplification of the inflammatory response by releasing 49 
muramyl-peptides (6). Depending on the bond they cleave, autolysins are classified as lytic 50 
tranglycosylases, N-acetylmuramidases, N-acetylglucosaminidases, N-acetylmuramoyl L-alanine 51 
amidases, or endopeptidases.  52 
In Enterococcus faecalis, two autolytic activities have been described (12). One of the 53 
corresponding proteins, designated AtlA in this report, has been identified (4, 18) but its activity 54 
has not been characterized. AtlA is a three-domain enzyme composed of an N-terminal 55 
threonine- and glutamic acid-rich (T/E-rich) domain of unknown function (domain I), a central 56 
putative catalytic domain (domain II) and a C-terminal cell wall binding domain consisting of six 57 
LysM modules (domain III) (3). In this study, we have identified the peptidoglycan bond cleaved 58 
by AtlA and analyzed the contribution of the domains of the protein to its enzyme activity. 59 
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MATERIALS AND METHODS 60 
Bacterial strains, plasmids, and growth conditions. All strains and plasmids used in this 61 
study are described in Table 1. The bacteria were grown at 37°C in Brain Heart Infusion broth or 62 
agar (15 g/l) (BHI, Difco laboratories, Detroit, USA). When required, the growth medium was 63 
supplemented with 100 µg/ml ampicillin and 50 µg/ml kanamycin. 64 
Plasmid construction. To construct pML118 encoding amino acids 54 to 737 of AtlA 65 
(domains I-II-III), V583 genomic DNA (19) was PCR-amplified using Vent DNA polymerase 66 
(Biolabs) and oligonucleotides EF0799-1 and EF0799-4 (Table 1). The resulting fragment was 67 
cloned in frame with the hexahistidine sequence of pET2818, a pET2816b derivative (9), using 68 
NcoI and BamHI. The same cloning procedure was used to obtain pML318 (encoding domains I-69 
II of AtlA, amino acids 54 to 335) with primers EF0799-1 and EF0799-2; pML418 (encoding 70 
domain II, amino acids 182 to 335) with EF0799-3 and EF0799-2; and pML518 (encoding 71 
domain III, amino acids 335 to 737) with EF0799-5 and EF0799-4. 72 
Production and purification of histidine-tagged AtlA and its derivatives. E. coli BL21 73 
DE3 (pREP4GroESL) (1) harboring recombinant plasmids were grown at 37°C in BHI broth 74 
containing kanamycin and ampicillin. When the cultures had reached an optical density at 600 75 
nm of 0.7, production of the recombinant protein was induced by addition of 0.5 mM isopropyl-76 
β-D-thiogalactopyranoside (IPTG) and incubation was continued for 12 h at 16°C. The cells were 77 
harvested, washed, and resuspended in buffer A (50 mM Tris-HCl, pH 7.5, 300 mM NaCl). 78 
Crude lysates were obtained by sonication (6 times 30 sec, 20 % output, Branson Sonifier 450). 79 
Proteins were loaded onto Ni2+-nitrilotriacetate agarose resin (Qiagen GmbH, Hilden, Germany) 80 
and eluted with stepwise increasing concentrations of imidazole (25, 50, 100, and 250 mM in 81 
buffer A). AtlA eluting at 100 mM imidazole was further purified by anion exchange 82 
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chromatography (MonoQ column, Amersham biosciences, Uppsala, Sweden) using a 0 to 1 M 83 
NaCl gradient in 25 mM ethanolamine (pH 9.25). The concentration of purified proteins was 84 
determined using the BIO-RAD Protein Assay (BIO-RAD Laboratories GmbH, Postfach, 85 
Germany). 86 
AtlA derivatives were purified by the same method except that a single affinity 87 
chromatography step was carried out. 88 
Proteolysis of AtlA. Purified AtlA (10 µg) was incubated with 10 ng of proteinase K 89 
(Boehringer GmbH, Ingelheim, Germany) in 20 µl of 25 mM Tris-HCl, pH 7.5, 25 mM NaCl, 90 
0.5 mM MgCl2, and 2 mM CaCl2 (buffer B). After various incubation times at 37°C (1 to 10 91 
min), aliquots were withdrawn and digestion was stopped by adding phenylmethylsulfonyl 92 
fluoride to a final concentration of 2 mM. The samples were analyzed by SDS–PAGE. For N-93 
terminal sequencing, proteins were transferred onto polyvinylidene difluoride membranes by 94 
passive absorption and sequenced using a Perkin-Elmer Procise 494 HT protein sequencer as 95 
described elsewhere (10).  96 
To prepare AtlA with a truncated domain I, 400 µg of purified protein were digested with 12.5 97 
ng of proteinase K for 3 h at 37°C in 500 µl of buffer B. The digestion products were separated 98 
by size exclusion chromatography on a Superdex75 HR 10/30 column (Amersham biosciences, 99 
Uppsala, Sweden) equilibrated with 20 mM Tris-HCl, pH 7.5, 100 mM NaCl. The fractions 100 
containing undigested AtlA and partially digested AtlA were analyzed by SDS-PAGE, pooled 101 
separately, and tested for activity. 102 
Cell wall purification and peptidoglycan structural analysis. Bacteria were grown in 500 ml 103 
of BHI broth at 37 °C to an optical density at 650 nm of 0.7. Peptidoglycan was extracted by 104 
treating the bacterial pellet with 14 ml of 4% SDS at 100 °C for 30 min. Peptidoglycan was 105 
washed five times by centrifugation (12,000 x g for 10 min at 20 °C) with 20 ml of water. 106 
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Peptidoglycan was serially treated overnight at 37 °C with Pronase (200 µg/ml) in 1 ml of Tris-107 
HCl (10 mM, pH 7.4) and with trypsin (200 µg/ml) in 1 ml of phosphate buffer (20 mM, pH 7.8). 108 
Peptidoglycan was washed twice with 20 ml of water and digested overnight with mutanolysin 109 
(45 µg/ml; Sigma-Aldrich) or  AtlA(200 µg/ml) at 37 °C in 1 ml of phosphate buffer (25 mM, 110 
pH 6.0) containing MgCl2 (0.1 mM). soluble disaccharide peptides were recovered by 111 
ultracentrifugation (100,000 x g for 30 min at 20 °C). For reduction of MurNAc to N-112 
acetylmuramitol or GlcNAc to N-acetylglucosaminitol, equal volumes (200 µl) of the solution of 113 
disaccharide peptides and of borate buffer (250 mM, pH 9.0) were mixed. Two mg of sodium 114 
borohydride were added, and the solution was incubated for 20 min at room temperature. The pH 115 
of the solution was adjusted to 4.0 with 20% orthophosphoric acid. 116 
The reduced muropeptides were separated by reverse-phase high-performance liquid 117 
chromatography (rp-HPLC) on a C18 column (3 µm, 4.6 by 250 mm; Interchrom, Montluçon, 118 
France) at a flow rate of 0.5 ml/min with a 0 to 20 % gradient applied between 10 and 90 min 119 
(buffer A, 0.05 % [vol/vol] trifluoroacetic acid in water; buffer B, 0.035 % [vol/vol] 120 
trifluoroacetic acid in acetonitrile). Mass spectral data were collected with an electrospray time-121 
of-flight mass spectrometer operating in the positive mode (Qstar Pulsar I; Applied Biosystems, 122 
Courtaboeuf, France). The data were acquired with a capillary voltage of 5,200 V and a 123 
declustering potential of 20 V. The mass scan range was from m/z 350 to 1,500, and the scan 124 
cycle was 1s. Tandem mass spectrometry was carried out as previously described (2). 125 
Determination of peptidoglycan hydrolase activity. Hydrolysis of purified cell walls 126 
(200 µg/ml) was measured using an Ultrospec 2000 spectrophotometer (Amersham biosciences, 127 
Uppsala, Sweden) and following the decrease in turbidity at 450 nm for 1 h at 37°C in 25 mM 128 
Tris-HCl, pH 7.5, 100 mM NaCl buffer. Various dilutions of AtlA and its derivatives were tested 129 
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to identify conditions in which the velocity of hydrolysis was proportional to enzyme 130 
concentration. Enzymatic activity was expressed as A450 units per min per mmol of protein.  131 
To determine the optimal pH for AtlA activity, a buffer containing 30 mM malonic acid, 132 
30 mM sodium phosphate, 30 mM Tris-HCl, and 30 mM ethanolamine was prepared and the pH 133 
adjusted as required.  134 
To determine whether partial proteolysis stimulated AtlA activity, 25 ng of proteinase K was 135 
added to the reaction mixture containing 1 µg of AtlA in a final volume of 1 ml. In these 136 
experiments, aliquots were analyzed by SDS-PAGE to monitor partial digestion of AtlA. 137 
For zymogram analysis, crude extracts were separated by SDS-PAGE using gels containing 138 
0.2 % autoclaved Micrococcus lysodeikticus cells. After electrophoresis, the proteins were 139 
renatured by incubating the gel for 24 h in 25 mM Tris (pH 8.0) buffer containing 0.1 %Triton at 140 
37°C. Lytic activities could be visualized as clear bands on the opaque SDS-PAGE gel.  141 
Analysis of the LysM-peptidoglycan interaction. Purified peptidoglycan (100 µg) was 142 
incubated with purified LysM domain III (10 µg) in 20 mM Tris-HCl (pH 8.0), 500 mM NaCl in 143 
a final volume of 125 µl for 30 min at 4°C under agitation. The suspension was centrifuged for 144 
10 min at 15,000 g and the supernatant (soluble fraction) was kept for further analyses. The pellet 145 
was washed twice with 250 µl of buffer and resuspended in 125 µl of buffer (insoluble fraction). 146 
Unbound proteins in the soluble fractions and bound proteins in the insoluble fractions were 147 
analyzed by 12% SDS–PAGE. 148 
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RESULTS AND DISCUSSION 149 
Enzymatic activity and purification of recombinant AtlA. Mature AtlA (residues 54 to 737, 150 
EF0799 at www.tigr.org or ALYS_ENTFA, accession P37710 in Swissprot) was produced in E. 151 
coli as a C-terminally histidine-tagged protein and purified using affinity and anion exchange 152 
chromatography (Fig. 1A). The purified recombinant protein migrated as a 72 kDa polypeptide 153 
band on SDS-PAGE in agreement with the predicted molecular mass of 72,540 kDa. A faint 154 
polypeptide band of approximately 62 kDa was present in all the purification steps (data not 155 
shown). Storage of the recombinant enzyme at 4°C for eight weeks led to an increase in the 156 
abundance of this 62 kDa polypeptide, indicating that it resulted from proteolysis (data not 157 
shown).  158 
The optimal pH for the activity of recombinant AtlA was 7.0 at 37°C (Fig. 1B). Pre-incubation 159 
of the enzyme (at a concentration of 15 nM) in 10 mM EDTA did not inhibit its activity 160 
indicating that divalent cations are not essential for AtlA activity. AtlA was more active on M. 161 
lysodeikticus (1,900 ± 290 U), a reference substrate for autolysins, than on E. faecalis 162 
peptidoglycan (350 ± 20 U). The fact that M. lysodeikticus peptidoglycan is more susceptible to 163 
AtlA than homologous peptidoglycan could be due to an unusually high amount of unsubstituted 164 
MurNAc residues leading to a low cross-linked molecule therefore quickly solubilized by the 165 
enzyme (14). Alternatively, a lower degree of O-acetylation of the M. lysodeikticus peptidoglycan 166 
could explain this difference as O-acetylation has been shown to modulate autolysin activity (5, 167 
22). 168 
Determination of AtlA hydrolytic bond specificity. To identify the peptidoglycan bond 169 
cleaved by AtlA, we compared the structure of the muropeptides obtained after hydrolysis of E. 170 
faecalis OG1RF peptidoglycan by the purified AtlA protein and a commercially available 171 
muramidase (mutanolysin). After digestion and reduction, the muropeptides were separated by 172 
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rp-HPLC on a C18 column (Fig. 2A and 2B) and the peaks containing the main monomers, 173 
dimers, trimers and tetramers were analyzed by mass spectrometry (MS) (Fig. 2C). The major 174 
muropeptides obtained with mutanolysin (peaks 1 to 8) had the same mass as their counterparts 175 
obtained after digestion with the purified AtlA protein (peaks 1’ to 8’), confirming that AtlA 176 
cleaves the glycan moiety of the peptidoglycan. N-acetylglucosaminidases and N-177 
acetylmuramidases generate muropeptides carrying GlcNAc or MurNAc at the reducing end of 178 
the disaccharide, respectively. To discriminate between these two activities, tandem mass 179 
spectrometry (MS/MS) was performed on the major muropeptide monomer generated by 180 
mutanolysin (Fig. 3A) and AtlA (Fig. 3B). Fragmentation of the ion at m/z 1110.6, corresponding 181 
to the [M+H]+ form of a reduced disaccharide-pentapeptide substituted by an L-alanyl-L-alanyl 182 
side chain (DS-penta[AA]), led to different patterns for the two enzymes. For mutanolysin, loss 183 
of unreduced GlcNAc gave an ion at m/z 907.55 as previously described (24). For AtlA, loss of 184 
reduced GlcNAc gave an ion at m/z 887.50. Additional loss of alanyl residues from the C-185 
terminus of the pentapeptide or the N-terminus of the side chain gave additional ions 186 
characteristic of the muropeptides generated by mutanolysin (Fig. 3A) and AtlA (Fig. 3B), 187 
carrying either unreduced or reduced GlcNAc respectively. As expected, ions corresponding to 188 
peptides resulting from the loss of both sugars were found in the two fragmentation patterns. 189 
These data show that MS/MS is a powerful method for discriminating between muropeptides 190 
generated by N-acetylmuramidases and those generated by N-acetylglucosaminidases and clearly 191 
demonstrates that AtlA displays the latter specificity (EC 3.2.1.52). Characterization by other 192 
techniques of autolysins related to AtlA indicated that the protein family includes both N-193 
acetylmuramidases, such as Mur-2 from E. hirae (11), and N-acetylglucosaminidases, such as 194 
AcmA from Lactococcus lactis (21) and LytG from Bacillus subtilis (15).  195 
H
AL author m
anuscript    inserm
-00156004, version 1
 10 
Domain organization of AtlA. Sequence comparison (data not shown) revealed that the three 196 
domains of the AtlA protein are present in different combinations in proteins from various 197 
databases, allowing approximate boundaries to be defined as depicted in Fig. 4A. The T/E-rich 198 
region is found in E. faecalis AtlA homologs (EF0252 and EF1823; www.tigr.org) as well as in 199 
Enterococcus faecium AtlA homologs (contig 643 and 533; http://genome.jgi-psf.org, database 200 
released June 2004). No function has been assigned to this low complexity region. The central 201 
domain is similar to the catalytic domain of several autolysins from Gram-positive bacteria 202 
including B. subtilis, L. lactis, E. hirae (see above), as well as those from E. faecium, 203 
Staphylococcus aureus, Streptococcus pyogenes or Listeria monocytogenes. Finally, the LysM 204 
domain is composed of six LysM modules of approximately 50 amino acids. These modules form 205 
βααβ secondary structures separated by intervening sequences of 15-20 residues (3). LysM 206 
modules occur most often in cell wall degrading enzymes but are also present in many other 207 
bacterial proteins (3). The LysM modules bind to peptidoglycan but the nature of the interaction 208 
remains to be characterized. 209 
In this study, we have developed two approaches to gain insights into the role of the three 210 
domains of AtlA in its enzyme activity. First, fragments of the atlA open reading frame were 211 
cloned in an E. coli expression vector and the corresponding polypeptides were purified. Second, 212 
AtlA was partially digested by proteinase K to experimentally probe its domain organization and 213 
identify sites sensitive to proteolytic cleavage that might be involved in activation of a putative 214 
proenzyme. 215 
Purification of AtlA domains produced in E. coli. The polypeptides corresponding to the 216 
different domains of AtlA were produced in E. coli and purified by affinity chromatography as 217 
described in the Materials and Methods section. Domain II alone, domain III alone and domains 218 
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I-II were successfully purified to homogeneity (Fig. 4B). As domains II-III were produced at a 219 
very low level in E. coli, this fragment of AtlA was generated by partial digestion of the mature 220 
protein (see below).  221 
Probing of the structural organization of AtlA by limited proteinase K digestion. The first 222 
cleavage by proteinase K generated a protease-resistant core (polypeptide A, Fig. 4C) with an 223 
estimated molecular weight of 62 kDa. A polypeptide with a similar apparent molecular weight 224 
displaying lytic activity against M. lysodeikticus cells was detected in crude extracts of E. faecalis 225 
(Fig. 4D, lane 1). Since no autolytic activity is detected in crude extracts of the E. faecalis 226 
OG1RF atlA mutant (Fig. 4D, lane 2), these results suggested that AtlA is cleaved in vivo in the 227 
original host. The N-terminal sequence of the 62 kDa polypeptide obtained in vitro was SALSPT, 228 
indicating a cleavage between Phe 171 and Ser 172, near the transition between domain I and II 229 
as deduced from sequence analysis (Ser 181 – Glu 182; Fig. 4A). The corresponding fragment 230 
was purified by size-exclusion chromatography (Fig. 4E) for enzymatic analyses. Further 231 
proteolysis events (Fig. 4C) gave rise to polypeptides B (56 kDa) and C (50 kDa). These 232 
polypeptides had the same N-terminal sequence, suggesting that they resulted from the sequential 233 
loss of one or two LysM modules (ca. 6 kDa) from the C-terminus of the protein.  234 
The central domain of AtlA is catalytically active. Domain II alone displayed enzymatic 235 
activity although it was much less active than AtlA (4.85 ± 0.4 U vs 1,900 ± 290 U). This result 236 
confirmed that domain II is the catalytic domain of AtlA and indicated that one or both of the N-237 
terminal and the C-terminal domains are required for optimal activity.  238 
The N-terminal T/E-rich domain does not function as a propeptide. As described above, 239 
the zymogram of E. faecalis crude extracts indicated that AtlA is cleaved by endogenous 240 
proteases (Fig. 4D). To test whether domain I functions as a propeptide, we compared (i) the 241 
activity of domains I-II-III with that of domains II-III and (ii) the activity of domains I-II with 242 
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that of domain II alone. The activity of AtlA was similar to that of domains II-III (1,900 ± 290 U 243 
vs 2,830 ± 420 U, respectively). Similarly, the activity of domains I+II was similar to that of 244 
domain II alone (6.97 ± 0.9 U vs 4.85 ± 0.4 respectively). In agreement with these results, the rate 245 
of hydrolysis of M. lysodeikticus peptidoglycan by AtlA did not increase upon addition of 246 
proteinase K to the reaction mixture (data not shown). Since the addition of exogenous proteases 247 
increases the autolysis rate in E. faecalis (18), it is likely that another autolysin (different from 248 
AtlA) is activated by proteolysis in this bacterium. This putative autolysin could be related to the 249 
E. hirae Mur-1 enzyme, which is also activated by proteolysis (16). Further experiments are 250 
required to identify the role of the T/E-rich region, which may be involved in post-translational 251 
modification of AtlA, sub-cellular targeting or interaction with protein(s) modulating its activity. 252 
The LysM domain is critical for AtlA activity. As expected, domain III (consisting of six 253 
LysM modules) displayed no enzymatic activity and was able to bind peptidoglycan in vitro (data 254 
not shown). The impact of the LysM domain on AtlA activity was tested by comparing (i) the 255 
activity of domains I-II-III with that of domains I-II and (ii) the activity of domains II-III with 256 
that of domain II alone. Truncation of domain III from the full length protein led to a 270-fold 257 
reduction in activity. Similarly, the truncation of domain III from domains II-III led to a 580-fold 258 
reduction of activity. Altogether, our results show that cell wall binding is critical for full AtlA 259 
activity. Zymogram analyses have been used to investigate the activity of AcmA from L. lactis 260 
which is made of a catalytic domain fused to a C-terminal LysM domain. Deletion of the LysM 261 
modules of AcmA led to an inactive protein indicating that the peptidoglycan-binding domain is 262 
also important for the activity of this autolysin (21). The critical role of LysM modules suggests 263 
that the activity of autolysins may be controlled at the level of binding of the enzymes to their 264 
substrate. The binding onto the cell wall may increase the local concentration of the enzyme or 265 
may provide proper positioning of the catalytic domain towards its substrate. Alternatively the 266 
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LysM domain may be required to induce a proper conformation of the catalytic domain as 267 
described for the Streptococcus pneumonie LytA autolysin (7). 268 
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 FIGURE LEGENDS 347 
Figure 1. Purification of AtlA and determination of the optimal pH for activity. (A) 348 
Purification of AtlA: lane 1, Crude extract of BL21 DE3 (pREP4GroESL) transformed with 349 
pET2818 after IPTG induction (15 µg of protein); lane 2, crude extract of BL21 DE3 350 
(pREP4GroESL) transformed with pML118 after IPTG induction (15 µg); lane 3, protein fraction 351 
eluting from metal affinity chromatography with 100 mM imidazole (5 µg); lane 4, protein 352 
fraction eluted with 100-200 mM NaCl from the anion-exchange column (4 µg). (B) pH activity 353 
profile of AtlA. Enzymatic activity was assayed on M. lysodeikticus cell walls at 37°C. 354 
 355 
Figure 2. Digestion of E. faecalis peptidoglycan by mutanolysin and AtlA. Rp-HPLC 356 
muropeptide profiles of OG1RF peptidoglycan digested by mutanolysin (A) or AtlA (B). The 357 
mass and predicted structures for peaks 1 to 8 and 1’ to 8’ are described in (C).  358 
 359 
Figure 3. Determination of AtlA cleavage specificity by MS/MS. The major muropeptide 360 
monomers generated by mutanolysin (peak 2) and AtlA (peak 2') were analyzed by MS/MS 361 
yielding fragmentation patterns (A) and (B), respectively. The m/z values of the most informative 362 
ions are boxed and the inferred structures are indicated with a one-letter code: M, MurNAc; MR, 363 
reduced MurNAc; G, GlcNAc; GR, reduced GlcNAc; A, L-Ala or D-Ala; Lac, D-lactate; K, L-364 
Lys; Q, D-iso-Gln.  365 
 366 
Figure 4. Domain organization of AtlA. (A) Domain organization of AtlA deduced from 367 
sequence analysis. SP, signal peptide; T/E-rich, threonine- and glutamic acid-rich region 368 
(domain I); Catalytic, catalytic domain (domain II); LysM, LysM domain (domain III). (B) 369 
Purification of AtlA and its derivatives overexpressed in E. coli. Lane 1, domains I-II (2 µg); lane 370 
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2, domain II alone (2 µg); lane 3, domain III alone (4 µg). (C) Limited digestion of AtlA by 371 
proteinase K. Full length AtlA (10 µg, lane 1) was digested with proteinase K and aliquots were 372 
withdrawn after 1 min (lane 2), 5 min (lane 3) or 10 min (lane 4). The three polypeptides A, B C 373 
(indicated by an arrow) were subjected to N-terminal sequencing. (D) Zymogram showing cell 374 
wall lytic activity of AtlA. Proteins were separated by SDS-PAGE in a gel containing 0,2% of 375 
autoclaved M. lysodeikticus cells, renatured in situ, and incubated at 37°C. Lane 1, crude extract 376 
of OG1RF (20 µg); lane 2, crude extract of OG1RF atlA (20 µg) (18). (E) Purification of 377 
truncated AtlA lacking the  N-terminal domain. The full length AtlA was subjected to limited 378 
digestion by proteinase K. The digestion products were loaded on a size-exclusion column to 379 
separate undigested AtlA (domains I-II-III) from AtlA devoid of its N-terminal region (domains 380 
II-III). Inset: lane 1, undigested AtlA; lane 2, partial digest; lane 3, purified peak a; lane 4, 381 
purified peak b. The unexpected high retention time of domains II-III could result from non 382 
specific interaction of this polypeptide with the sephadex matrix of the column. 383 
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Table 1. Bacterial strains, plasmids and oligonucleotides. 
Strains/plasmids/oligonucleotides Relevant properties Source 
Strains   
Enterococcus faecalis   
V583 Sequenced strain (clinical isolate) (18) 
OG1RF  (17) 
OG1RF atlA  (17) 
Micrococcus lysodeikticus   
ATCC4698  Pasteur 
Institute 
Escherichia coli    
BL21(DE3) pREP4GroESL Expression strain (1) 
XL1-blue Cloning strain Stratagene 
Plasmids   
pET28/16 pET28a derivative (7) 
pET2818 pET28/16 variant for C-terminal Histidine-tag fusion Lab stock 
pML118 pET2818 carrying an AtlA fragment encoding residues 54 to 737  This work 
pML318 pET2818 carrying an AtlA fragment encoding residues 54 to 335 This work 
pML418 pET2818 carrying an AtlA fragment encoding residues 182 to 335 This work 
pML518 pET2818 carrying an AtlA fragment encoding residues 335 to 737 This work 
Oligonucleotides Sequence (5’→3’)  
EF0799-1 ttccatggggacagaagagcagccaacaaatgc  
EF0799-2 ttggatcagaagatggtgtatcatattg  
EF0799-3 ttccatggggtcagaatttattgccgagttagc  
EF0799-4 ttggatccaccaacttttaaagtttgaccaa  
EF0799-5 aaaccatgggaacgaacacgtactatactgtaaaatc  
 
H
AL author m
anuscript    inserm
-00156004, version 1
H
AL author m
anuscript    inserm
-00156004, version 1
H
AL author m
anuscript    inserm
-00156004, version 1
H
AL author m
anuscript    inserm
-00156004, version 1
H
AL author m
anuscript    inserm
-00156004, version 1
